Yoseph A Mekori

Yoseph A Mekori


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2017 in Annual Review of Pathology: Mechanisms of Disease
Verified
Journal Article
Closed access
DMDean D. Metcalfe
Dean D. Metcalfe
YMYoseph A Mekori
Yoseph A Mekori
Systemic mastocytosis is a clonal disorder of mast cells that may variably present with characteristic skin lesions, episodes of mast cell mediator release, and disturbances of hematopoiesis. No curative therapy presently exists. Conventional management has relied on agents that antagonize mediators released by mast cells, inhibit mediator secretion, or modulate mast cell proliferation. Recent advances in the molecular understanding of the pathophysiology of systemic mastocytosis have provided new therapeutic considerations, including new and novel tyrosine kinase inhibitors.

1 June 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
ISIrit Shefler
Irit Shefler
PSPazit Salamon
Pazit Salamon
FLFrancesca Levi-Schaffer
Francesca Levi-Schaffer
AMAdam Mor
Adam Mor
AHAlon Y. Hershko
Alon Y. Hershko
YMYoseph A Mekori
Yoseph A Mekori

Verified
Journal Article
Open access
PDF file
ISIrit Shefler
Irit Shefler
PSPazit salamon
Pazit salamon
YMYoseph A Mekori
Yoseph A Mekori
Allergic inflammation is accompanied by the coordinated expression of numerous genes and proteins that initiate, sustain, and propagate immune responses and tissue remodeling. MicroRNAs (miRNAs) are a large class of small regulatory molecules that are able to control the translation of target mRNAs and consequently regulate various biological processes at the posttranscriptional level. MiRNA profiles have been identified in multiple allergic inflammatory diseases and in the tumor microenvironment. Mast cells have been found to co-localize within the above conditions. More specifically, in addition to being essential in initiating the allergic response, mast cells play a key role in both innate and adaptive immunity as well as in modulating tumor growth. This review summarizes the possible role of various miRNAs in the above-mentioned processes wherein mast cells have been found to be involved. Understanding the role of miRNAs in mast cell activation and function may serve as an important tool in developing diagnostic as well as therapeutic approaches in mast cell-dependent pathological conditions.